Source:http://linkedlifedata.com/resource/pubmed/id/15624028
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2004-12-29
|
pubmed:abstractText |
The pharmacokinetics of diclofenac sodium in healthy volunteers was evaluated to determine if previously repeated doses of ranitidine inhibited the metabolism of the non-steroidal anti-inflammatory drug. Diclofenac sodium 50 mg (tablets) in combination with ranitidine 150 mg (tablets) were administered to 14 healthy human volunteers in a two treatment study design, separated by 5 days in which the ranitidine alone was administrated in single p.o. doses twice daily. Plasma concentrations of diclofenac were determined during a 12 hour period following drug administration. Diclofenac plasma concentrations were determined by a validated RP-HPLC method. Pharmacokinetic parameters were calculated with compartmental and non-compartmental analysis. In the two periods of treatments, the mean peak plasma concentrations Cmax were 1503.9 ng/ml (diclofenac alone) and 1742.5 ng/ml (diclofenac and ranitidine). The time taken to reach the peak, Tmax, was 0.85 hrs, and 0.82 hrs, respectively. The areas under the curve (AUC0-6) were 1479.9 ng x hr/ml and 1650.3 ng x hr/ml, respectively. Statistically insignificant difference was observed in these pharmaco-kinetic parameters of diclofenac sodium when administered alone or after 5 days of treatment with ranitidine. The experimental data did not suggest any consistent effects of ranitidine upon the pharmacokinetics of diclofenac sodium.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1221-4167
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
306-8
|
pubmed:meshHeading |
pubmed-meshheading:15624028-Adult,
pubmed-meshheading:15624028-Analysis of Variance,
pubmed-meshheading:15624028-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:15624028-Biological Availability,
pubmed-meshheading:15624028-Diclofenac,
pubmed-meshheading:15624028-Drug Interactions,
pubmed-meshheading:15624028-Histamine H2 Antagonists,
pubmed-meshheading:15624028-Humans,
pubmed-meshheading:15624028-Metabolic Clearance Rate,
pubmed-meshheading:15624028-Ranitidine
|
pubmed:year |
2004
|
pubmed:articleTitle |
No effect of short term ranitidine intake on diclofenac pharmacokinetics.
|
pubmed:affiliation |
3rd Pediatric Clinic, University of Medicine and Pharmacy, Str. Campeni 2-4, Cluj-Napoca, Romania.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|